J
Juice Authority
Guest
Riker29 said:
Yes I have but we're discussing alternatives to clomid therapy, which in part includes Nelson's post cycle formula.
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Riker29 said:
muscleup said:I'm running Proviron@50 mgs per day along with .25 mgs per day of arimidex...I have done this all the way through clomid therapy...I have actually increased my strength post cycle...My questin being, Am I just wasting my arimidex ?...Could the proviron do the trick by itself... ?
So you are saying run the Nolva instead of arimidex ?..I was actaully running the Arimidex along with some clen. I'm trying to get rid of or at least reduce some a2 fat deposits that I have acquired from Bulking...Juice Authority said:
Well, it's hard to say for sure since there is no real concrete evidence that shows Proviron keeps estrogen from binding to the HPTA but Nolva would be a much better option since it accomplishes the same thing without messing up your lipid profile. Nolva actually improves your lipid profile.
Well thats good cause the Arimidex(Astra Zeneca) is WAY more expensive than the Nolvadex...Karma bro...ThanksJuice Authority said:
imo, yes. Nolva should work to reduce some of those estrogen related fat deposits. In fact, Nolva is the only anti-e that has clinically been shown the reverse gyno after it's been formed.
I took a blood test after my PCT therapy where I was using 1mg of Arimidex Eod and my HDL was 9 and my LDL was 230.
Arimidex, it is an anti-e. It stops aromatation. Problem is, it will mess up your cholesterol levels.
Arimidex = To Prevent Estrogen Creation
Nolvadex = To Stop Estrogen from Binding
Nolvadex can and will act as a psuedo-estrogen. Arimidex will keep your aromatose activity down to a minimum. Nolva can take the place for estrogenic activities for cholesterol. Which is good! Another noteworthy fact about Nolvadex is that it acts more potently as an estrogen in the liver.
Here's a study showing nolva lowers femara levels in the system when combined.
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.
Dowsett M, Pfister C, Johnston SR, Miles DW, Houston SJ, Verbeek JA, Gundacker H, Sioufi A, Smith IE.
Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom.
This study examined whether the addition of tamoxifen to the treatment regimen of patients with advanced breast cancer being treated with the aromatase inhibitor letrozole led to any pharmacokinetic or pharmacodynamic interaction. Twelve of 17 patients completed the core period of the trial in which 2.5 mg/day letrozole was administered alone for 6 weeks and in combination with 20 mg/day tamoxifen for the subsequent 6 weeks. Patients responding to treatment continued on the combination until progression of disease or any other reason for discontinuation. Plasma levels of letrozole were measured at the end of the 6-week periods of treatment with letrozole alone and the combination and once more between 4 and 8 months on combination therapy. No further measurements were done thereafter. Hormone levels were measured at 2-week intervals throughout the core period. Marked suppression of estradiol, estrone, and estrone sulfate occurred with letrozole treatment, and this was not significantly affected by the addition of tamoxifen. However, plasma levels of letrozole were reduced by a mean 37.6% during combination therapy (P<0.0001), and this reduction persisted after 4-8 months of combination therapy. Letrozole is the first drug to be described in which this pharmacokinetic interaction occurs with tamoxifen. The mechanism is likely to be a consequence of an induction of letrozole-metabolizing enzymes by tamoxifen but was not further addressed in this study. It is possible that the antitumor efficacy of letrozole may be affected. Thus, sequential therapy may be preferable with these two drugs. It is not known whether tamoxifen interacts with other members of this class of drugs or with other drugs in combination.
muscleup said:So you are saying run the Nolva instead of arimidex ?..I was actaully running the Arimidex along with some clen. I'm trying to get rid of or at least reduce some a2 fat deposits that I have acquired from Bulking...
JibbyJabba said:My only apprehension about Proviron is, due to its androgenic nature, that it seemingly is pretty rough on the hair... this is further confirmed by some of its users...
Can anyone shed anymore light Proviron with respect to hair loss?
Nelson Montana said:I'd also add that e related fat deposits, although not necessarily a total myth, are a bit of an exageration. e will increase water retention, which looks fat, but you can lose water. The actual fat thought to be gained from e is usually just good old fashioned fat. On the other hand, proviron does make you hard, but not so much from the actual reduction of e but the lessened water, the incresed free T and the fact that DHT seems to increase muscle hardness. (For reasons I'm not fully sure of).
BodyByFinaplix said:
Good point. I've noticed the hardening effect when on proviron. Anyone have an answer on why DHT derivatives (such as proviron, primo and winstrol) see to increae muscle hardness? There has to be a reason, anyone have a solid theory on this?